Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial

Condition:   Staphylococcal InfectionInterventions:   Drug: Mupirocin calcium;   Drug: Mupirocin calciumSponsor:   National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified February 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials